TrialEuropean journal of heart failure2025

End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2).

Adriaan A Voors et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.